Division of Geriatric Medicine

Department of Medicine

Promising young scientists from colleges across the UVM campus gathered recently to celebrate the broad training experience, varied investigations, and collaborative community of UVM’s postdoctoral scholars. Organized by the UVM Postdoctoral Association, the event provided a chance for the scholars to present their research and network with peers.

The Larner College of Medicine medical Class of 2023 Honors Night on May 15 featured recognition and awards for graduating medical students, faculty, and staff.

(MAY 17, 2023) NBC5 featured pulmonologist Anne Dixon, M.A., B.M.B.Ch., professor of medicine, in a story about recruiting millennials for a long-term nationwide Lung Health Cohort Study. The pioneering study will follow 4,000 young, healthy adults to paint a clearer picture of lung health and the factors involved in predicting and preventing lung disease.

The Larner College of Medicine has been at the vanguard of technology transfer over the past decade, supporting patents and commercialization of faculty research, which has led to several successful startups. Recent examples of commercially successful innovations by Larner faculty include Prolocor, a startup company focused on developing a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.

(MAY 10, 2023) With the COVID-19 public health emergency expiring on the national level, WCAX-TV interviewed Vermont Health Commissioner Mark Levine, M.D., associate dean for graduate medical education and professor of medicine, and Jan Carney, M.D., M.P.H., associate dean of public health and health policy and professor of medicine, about what changes Vermonters can expect.

(MAY 2, 2023) Jan Carney, M.D., M.P.H., associate dean for public health and health policy, professor of medicine, and director of the graduate public health program at Larner, was interviewed by WalletHub about the future of the nursing profession and how recent graduates can find success.

(APRIL 30, 2023) According to Medical Dialogues, a new study by pulmonologist Anne Dixon, B.M.B.Ch., professor and interim chair of medicine, and colleagues has found that people with asthma and obesity have significant dysfunction in the distal airways at baseline that worsens with methacholine.

(APRIL 26, 2023) CBS3 reported that Vermont legislators are contemplating a proposal to ban menthol and flavored tobacco products, including vapes, something medical experts say is crucial to preventing problems later in life. “It’s not a clear risk or outcome when you start smoking or vaping when you’re 16-17 years old. These are things that start to cause problems when you’re 40, 50, 60 years old,” said cardiologist Prospero Gogo, M.D., professor of medicine.

(APRIL 25, 2023) Mary Cushman, M.D., M.Sc., professor of medicine and of pathology & laboratory medicine, is a co-author of a study on COVID-19 vaccines and their alleged risk of causing blood clots that was highlighted in World Today News.

A new study in the American Journal of Physiology-Lung Cellular and Molecular Physiology by Albert van der Vliet, Ph.D., professor of pathology and laboratory medicine, and colleagues is honing in on why people with asthma often have worse symptoms if they are obese.

(APRIL 17, 2023) A study by Professor of Medicine Anne Dixon, B.M.B.Ch., and colleagues found that using oscillometry testing may allow physicians to identify patients with asthma and obesity who have a phenotype that may be related to worse symptoms and more severe disease, Healio.com reported.

The Office of Diversity, Equity and Inclusion at the Larner College of Medicine at the University of Vermont hosted the fourth annual Celebration of Gender Equity in Medicine and Science on March 2, 2023.

The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.

The University of Vermont Cancer Center now offers a novel, highly effective form of cancer treatment called CAR T-cell therapy, and recently began treating patients. The Cancer Center is the only health care institution in Vermont and northern New York to provide the treatment.

A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.

Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.

Sherrie Khadanga, M.D., M.S., assistant professor of medicine at UVM's Larner College of Medicine and assistant director of cardiac rehabilitation at the UVM Medical Center, was recently featured in a UVM Health Network HealthSource blog post titled "Women Find Strength with Cardiac Rehab" that focused on how High-Intensity Interval Training (HIIT) exercise can help women's recovery after a cardiac event.

(FEBRUARY 11, 2023) Mary Cushman, M.D., M.Sc., professor of medicine and director of the thrombosis and hemostasis program at the UVM Medical Center, recently spoke with The American Journal of Managed Care about racial trends in pulmonary embolism treatment and potential improvements compared with pre-pandemic trends.

(FEBRUARY 8, 2023) A randomized trial conducted by nephrologist Richard Solomon, M.D., professor of medicine, and colleagues found that a machine-learning intervention provided a higher level of safety during cardiac catheterization, lowering the chances of acute kidney injury (AKI), according to Health IT Analytics.

(FEBRUARY 7, 2023) Results of a study by Margaret Infeld, M.D., clinical cardiac electrophysiology fellow and clinical instructor in the Department of Medicine; cardiologist Markus Meyer, M.D., Ph.D., adjunct associate professor of medicine; and colleagues support heart rate modulation as a therapeutic intervention in HFpEF, according to HealthDay News.